Hot Products
| Catalog No. | Information |
| CFN90279 | Cyclo(Tyr-Hpro) Reference standards. |
| CFN90287 | Cyclo(Tyr-Leu) Cyclo(Tyr-Leu) shows cytotoxicity, antifungal,and anticoagulant activities. |
| CFN90278 | Cyclo(Tyr-Phe) Cyclo-(Phe-Tyr) shows anticoagulant activities. |
| CFN90276 | Cyclo(Tyr-Pro) Cyclo(Tyr-Pro) shows antibacterial activity towards several marine bacterial species, it also shows weak antagonistic activity against VEGFR2 -CD. Cyclo(Tyr-Pro) and cyclo(Pro-Val) are toxic to both suspension cells and seedlings of Pinus thunbergii, which may offer some clues to research the mechanism of pine wilt disease caused by pine wood nematode. |
| CFN90268 | Cyclo(Tyr-Val) Reference standards. |
| CFN97994 | Cycloartanol Cycloartanol is a natural product from Citrus medica. |
| CFN91779 | Cycloartenyl ferulate Cycloartenyl ferulate possesses several biological activities including anti-oxidative activity, antiallergic activity, anti-inflammatory and anticancer activities. |
| CFN99538 | Cycloastragenol Cycloastragenol has been shown to extend T cell proliferation by increasing telomarase activity showing that it may also help delay the onset of cellular aging; it is an extraordinary wound healing agent; it inhibits the apoptosis of PC12 induced by 6-OHDA, may be as potential neuroprotective agents in the treatment of Parkinson's disease. Cycloastragenol and astragaloside IV can suppress ROS-associated ER stress and then inhibit TXNIP/NLRP3 inflammasome activation with regulation of AMPK activity, and thereby ameliorate endothelial dysfunction by inhibiting inflammation and reducing cell apoptosis. Cycloastragenol and astragaloside IV have been shown to improve the proliferative response of CD8+ T lymphocytes from HIV-infected patients by upregulating telomerase activity, they also may exert their cellular effects through the activation of the Src/MEK/ERK pathway. |
| CFN92418 | Cyclocommunol Cyclocommunol exhibits cytotoxicity against hepatocellular carcinoma (SMMC-7721) and gastric carcinoma (BGC-823 and SGC-7901) cell lines. It also shows strong inhibition of arachidonic acid (AA)- and collagen-induced platelet aggregation. |
| CFN95103 | Cyclocurcumin Cyclocurcumin, a curcumin derivative, exhibits anticancer, anti-inflammatory, and immune-modulating abilities and is a potential compound for the treatment of rheumatoid arthritis as predicted by the MM-PBSA method. It may have a therapeutic potential as a novel antivasoconstrictive natural product. Cyclocurcumin offers higher neuronal protection than curcumin, they both reduced the level of ROS caused by MPP+ treatment. |
